Home›Industries›Healthtech
Healthtech Marketing Agency · HIPAA-Safe · Clinical + Payer + Provider GTM

The Healthtech Marketing Agency That Ships HIPAA-Safe Growth.

Retargeting that can’t touch PHI. Content that requires clinical review. YMYL search algorithms punishing weak E-E-A-T. Payer, provider, and clinician buyers each with their own procurement cycle. We build the marketing engine specifically for how digital health, medtech, RPM, and payer-tech companies actually acquire enterprise contracts.

HIPAA + BAA-ready Digital Health · Medtech · RPM Payer-tech · Provider SaaS
Pipeline, rankings, CAC, attribution, content, ABM — tell us the outcome you need
SEO, ABM, Paid Media, Content, Analytics, Web Dev, AI Ops, etc.
Quick Answer
What is a healthtech marketing agency?

A healthtech marketing agency runs SEO, demand generation, ABM, content, and paid programs specifically built for HIPAA-regulated digital health, medtech, RPM, payer-tech, and provider-SaaS companies. It handles the dual buyer (clinician + procurement), the medical-review content bottleneck, YMYL search-quality requirements, and PHI-safe retargeting. MV3 combines category SEO, AI-citation optimization, clinician-authored content, and compliance-safe ABM inside a BAA-covered engagement.

Why Healthtech Marketing Breaks Standard Playbooks

Six Pain Points We Fix Every Engagement.

These are the problems healthtech CMOs bring to the first call. They are the reason SaaS-marketing playbooks stop working the moment your product touches a chart, a claim, or a clinician.

01
HIPAA-Restricted Retargeting

You cannot drop a Meta pixel that fires on a page listing conditions. You cannot rebuild audiences from CRM data containing PHI. Standard retargeting stacks are landmines. You need a compliance-safe attribution and remarketing architecture built by someone who has already navigated OCR guidance.

02
Dual-Buyer Complexity

The clinician evaluates efficacy. Procurement evaluates cost and integration. Compliance evaluates BAA readiness. IT evaluates EHR integration. Each buyer has different content, different objections, and different decision timing, and they never talk to each other until day 90 of a 180-day cycle.

03
Medical-Review Content Bottleneck

Every content asset touching a clinical topic requires review by a licensed clinician. Your medical director has three hours per week for marketing. Content velocity crashes. Your competitors publish weekly; you publish quarterly.

04
YMYL Algorithm Penalties

Google’s Your-Money-Your-Life quality standards punish weak E-E-A-T on medical topics. Author credentials, peer-reviewed citations, medical-editor review process, and organizational trust signals are ranking factors. Most healthtech sites are missing four of the five.

05
Enterprise Procurement Cycle

Payer contracts run 9-18 months. Provider system contracts run 12-24 months. The buying committee expands from six to fifteen people across clinical, financial, IT, legal, and executive stakeholders. Standard demand-gen playbooks tuned for 30-day SaaS deals fail here.

06
AI Answer Layer Invisibility

Providers ask ChatGPT “best RPM platform for cardiology practices” and it names Livongo, Omada, and CentralReach. Challengers are invisible. Without a GEO program, LLMs recommend legacy incumbents on every category prompt buyers now search.

The MV3 Solutions Matrix

Every MV3 Service, Contextualized to Healthcare Buyers.

Same six-family MV3 catalog. Wired for how digital health, medtech, RPM, payer-tech, and provider-SaaS companies actually acquire enterprise contracts.

SEO
AI SEO

YMYL-compliant SEO rebuild across category prompts and specialty verticals. Author-credential architecture, medical-review signals, peer-cited content, and organizational E-E-A-T markup that actually satisfies Google’s health-quality raters.

SEO
GEO / LLMO

Get cited by ChatGPT, Perplexity, Gemini, Claude, and Google AIO when clinicians and procurement teams ask category questions. llms.txt, MedicalWebPage schema, and citation-earning content built for the corpus AI models pull medical answers from.

Demand Gen
ABM Agency

500 named provider systems, payers, and health-system accounts sequenced monthly. Enriched with EHR footprint (Epic, Cerner, athena), formulary data, and value-based-care contract signals. Buyer-committee mapped across clinical, IT, and procurement.

Demand Gen
Demand Generation

Guaranteed monthly qualified opportunities from the healthtech ICP. Base + per-SAO pricing tied to opportunities that pass clinical and procurement screens, not raw MQLs.

Demand Gen
Content Marketing

Clinician-authored content operation. Our writer bench includes practicing MDs, RNs, and health-economists. Medical review loop with a 5-day SLA. Peer-reviewed citations, author byline structured data, and YMYL-compliant editorial process.

Technical SEO
LinkedIn Ads

Compliance-safe LinkedIn matched-audience campaigns against named provider systems, health plans, and specialty medical group targets. Zero PHI exposure. Ad rotation by buyer stage and stakeholder role.

AI Ops
AI Operations

Custom AI CRM + intake workflows wired to your HubSpot / Salesforce Health Cloud. HIPAA-safe scoring, routing, and follow-up automation. BAA-covered infrastructure.

AI Ops
Analytics Setup

HIPAA-safe GA4, consent management, and attribution architecture. Server-side event handling. PHI-free conversion tracking so you can still measure marketing ROI without a compliance breach.

Strategy + Implementation

Both Halves. HIPAA-Safe. Clinically Credible.

Consulting shops write you a $220K strategy deck. Ad agencies burn ad spend without medical-review guardrails. MV3 does strategy and implementation, weekly, under one BAA-covered contract.

Strategy
Position for the clinician, the CFO, and the CIO simultaneously.

Every deliverable begins with the three-buyer job-to-be-done: the clinician needs efficacy evidence, the CFO needs unit economics, the CIO needs integration proof. We build category positioning, evidence architecture, and buyer-committee messaging around all three, not just clinical.

  • Category positioning against KLAS / Chilmark peer set
  • Three-buyer message maps (Clinical / Financial / IT)
  • YMYL-compliant content framework with medical-editor review protocol
  • HIPAA-safe attribution and remarketing architecture
  • Named-account list built against EHR footprint + payer-mix + VBC signals
Implementation
Clinician-authored content. Compliance-safe ads. HIPAA-safe attribution.

Strategy without execution is a slide deck sitting in your CMO’s inbox. Our clinical writer bench ships peer-reviewed-quality assets weekly. Our ABM team runs the 15-touch sequence against named health systems and payers. Our engineers deploy BAA-covered analytics and attribution.

  • Weekly clinician-authored content, medical-review approved
  • 15-touch multi-channel sequence orchestrated across 500 accounts
  • LinkedIn matched-audience campaigns at the clinical + financial title level
  • HIPAA-safe GA4 and consent architecture deployed
  • Monthly commercial review tied to signed contracts and pilot conversions
Aggregate Results Across Healthtech Engagements

Composite Metrics. BAA-Bound Clients. Real Movement.

Aggregated across digital health, medtech, RPM, payer-tech, and provider-SaaS engagements Trailing 12 months.

3.1×

Median lift in clinician + procurement inbound demo requests over 12 months

192%

Increase in category-keyword organic sessions from healthcare-buyer ICP

38%

Average reduction in enterprise procurement cycle when full ABM + content stack runs together

5.4×

Multiple of contracted-revenue pipeline generated per marketing dollar in Growth AI tier

Aggregate stats. Individual client names withheld under NDA and BAA per MV3 confidentiality policy.

Anonymized Engagement Vignette
Series C RPM Platform · Cardiology + Endocrinology · 16 Months

From zero AI citations to primary recommendation on 19 specialty prompts.

Client arrived with a clinically validated RPM product but zero organic pipeline. Content had been paused for six months awaiting medical-review capacity. Buying committee reach was limited to the clinician champion. CFOs and CIOs never engaged. Their previous agency had run Meta retargeting on a conditions page and OCR had opened an inquiry.

Full-stack engagement: HIPAA-safe attribution rebuild, YMYL content operation with practicing cardiologist and endocrinologist reviewers (8 pieces per month), GEO + llms.txt deployment, 500-account ABM program mapped across clinical / CFO / CIO stakeholders, LinkedIn campaigns segmented by specialty. By month 12, 19 category prompts cited them across four AI models, inbound from CFO and CIO titles had grown 3x, and their enterprise procurement cycle compressed from an average of 15 months to 9 months.

19
AI citations earned
3×
CFO / CIO inbound
-40%
Procurement cycle
192%
Organic sessions
Frequently Asked

Questions Healthtech Marketing Leaders Ask.

Do you sign BAAs?
Yes. Every healthtech engagement operates under a signed Business Associate Agreement. Our internal infrastructure (Supabase, HubSpot, n8n) is HIPAA-safe and our processes exclude PHI from any workflow that touches marketing systems.
Which healthcare categories have you run?
Digital health platforms, RPM and RTM, medtech / device SaaS, payer-tech (utilization mgmt, risk adjustment, member engagement), provider-SaaS (EHR-adjacent, revenue cycle, care management), and value-based-care enablement. We do not work on cash-pay direct-to-consumer supplements or unregulated wellness.
How do you handle clinical accuracy in content?
Every piece touching a clinical topic goes through a two-step review: our staff medical editor for foundational accuracy, then a specialty-board-certified reviewer for domain accuracy. Both sign off before publish. Author byline includes credentials, and every clinical claim carries a peer-reviewed citation.
Can you run paid ads without HIPAA exposure?
Yes. We do not use pixels on any page containing conditions, symptoms, or treatment information. Retargeting is done through consented email + LinkedIn matched audiences built from non-PHI data. Attribution is server-side with PHI stripping.
What about FDA-regulated claims?
We do not publish clinical-outcome or efficacy claims that fall under FDA jurisdiction without your regulatory team’s sign-off. For SaMD and device clients, we operate under your MRRC / promotional review committee.
What is the minimum engagement?
Growth AI at $5,997 per month, 12-month minimum. Healthcare procurement cycles do not respect quarterly retainers. The compounding effect of category SEO plus multi-touch ABM plus clinician content requires the 12-month view to show meaningful revenue movement.
What if we already have a Chief Medical Officer or medical director for content review?
Ideal. We build our content operation to loop your CMO in for domain-specific review at the specialty tier, while our staff medical editor handles the foundational accuracy pass. This preserves your CMO’s time for the review calls that only your organization can do.
How is progress measured?
Monthly commercial review with your VP Marketing, VP Sales, and CMO. Metrics: named accounts activated, clinical and financial-title inbound counts, signed pilots, contracted-revenue pipeline, and citation share across four AI models.
Program Lead
Vance Moore · Chief Growth Officer, MV3 Marketing

Vance oversees the MV3 team of SEO professionals, engineers, and auditors who run our healthtech vertical. Our team covers HIPAA-safe analytics and attribution architecture, YMYL content operations for digital health platforms, and compliance-safe ABM for payer-tech and provider-SaaS vendors. Vance signs off on every engagement and reviews every deliverable.

Q3 onboarding · 2 healthtech slots remaining

Ship compounding pipeline, without touching a byte of PHI.

Book a 30-minute strategy call with our healthtech GTM lead. We will map your buyer committee, diagnose your content and attribution setup live, and show the HIPAA-safe 12-month growth plan.

Book My Strategy Call →